We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Detachable Cardiac Pacing Lead to Improve Safety for Heart Patients

By HospiMedica International staff writers
Posted on 03 Jul 2024

Bypass surgery ranks as one of the most frequent open-heart surgeries, with the risk of mortality now nearly negligible. More...

Nonetheless, there are instances where the removal of temporary cardiac pacing leads results in fatal heart damage. These pacing leads are typically employed during the post-surgical recovery phase to monitor patients and mitigate the risk of postoperative arrhythmias, such as complete heart blockages. The existing procedures for lead placement, involving surgical stitches or direct electrode insertion into the heart tissue, can cause trauma during both the insertion and removal processes. This increases the likelihood of tissue damage, bleeding, and device malfunction. Now, new research, published in the journal Science Translational Medicine, has demonstrated findings that could offer a potential platform for adhesive bioelectronic devices for cardiac monitoring, diagnosis, and treatment, and pave the way for the future development of bioadhesive electronics.

A team from the Massachusetts Institute of Technology (MIT, Cambridge, MA, USA) has introduced a 3D-printable bioadhesive pacing lead that can directly interface with heart tissue, facilitating minimally invasive adhesive implantation and offering an easy detachment method for gentle removal. This innovation represents the first bioadhesive version of a temporary cardiac pacing lead that can be attached and detached on-demand, improving safety and bioelectronic performance with a trauma-free application and removal process. The development of this bioadhesive pacing lead merges several technologies previously developed by the team in the fields of bioadhesives, bioelectronics, and 3D printing.

The MIT researchers developed 3D-printable bioadhesive materials by graft-polymerizing polyacrylic acid on hydrophilic polyurethane and mixing with poly(3,4-ethylenedioxythiophene):poly(styrenesulfonate) (PEDOT:PSS) to enhance electrical conductivity. The resulting bioadhesive showed mechanical properties comparable to cardiac tissue and demonstrated strong adherence, ensuring stable electrical connectivity. In experimental studies using rat and porcine models, the bioadhesive pacing lead adhered solidly to cardiac tissue without causing visible tissue damage or bleeding during application or on-demand detachment. The device was compatible with standard clinical pacing systems and maintained a reliable electrical connection for cardiac monitoring and pacing over a period of 10 to 14 days in the animal models. These findings validate the potential of using printable adhesive electronics for cardiac pacing applications.

Related Links:
MIT


Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Bipolar Coagulation Generator
Aesculap
Adjustable Mobile Barrier
M-458
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.